Eligibility Type 2 Diabetes Mellitus NCT02186080

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age from 20 to 75
Descrizione

ID.1

Tipo di dati

boolean

at least 6 months from the diagnosis of type 2 diabetes
Descrizione

ID.2

Tipo di dati

boolean

current diabetes treatment: life style modification and/or metformin and/or sulfornylurea
Descrizione

ID.3

Tipo di dati

boolean

no change of the diabetes treatment (drug number and dossage) in recent 3 months
Descrizione

ID.4

Tipo di dati

boolean

hba1c 6.5% to 10%
Descrizione

ID.5

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
recent cardiovascular event in 6 months
Descrizione

ID.6

Tipo di dati

boolean

concurrent use of statin or fibrate or ezetimibe
Descrizione

ID.7

Tipo di dati

boolean

renal failure, chronic liver disease
Descrizione

ID.8

Tipo di dati

boolean

pregnancy or lactation
Descrizione

ID.9

Tipo di dati

boolean

use of other dpp-4 inhibitor or glp-1 analogue in recent 3 months
Descrizione

ID.10

Tipo di dati

boolean

Similar models

Eligibility Type 2 Diabetes Mellitus NCT02186080

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age from 20 to 75
boolean
ID.2
Item
at least 6 months from the diagnosis of type 2 diabetes
boolean
ID.3
Item
current diabetes treatment: life style modification and/or metformin and/or sulfornylurea
boolean
ID.4
Item
no change of the diabetes treatment (drug number and dossage) in recent 3 months
boolean
ID.5
Item
hba1c 6.5% to 10%
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
recent cardiovascular event in 6 months
boolean
ID.7
Item
concurrent use of statin or fibrate or ezetimibe
boolean
ID.8
Item
renal failure, chronic liver disease
boolean
ID.9
Item
pregnancy or lactation
boolean
ID.10
Item
use of other dpp-4 inhibitor or glp-1 analogue in recent 3 months
boolean